Send Message

Semaglutide Ozempic CAS No 910463-68-2 Peptide 2mg/Vial 5mg/Vial Semaglutide USPI

10 vials
MOQ
Negotiable
Price
Semaglutide Ozempic CAS No 910463-68-2 Peptide 2mg/Vial 5mg/Vial Semaglutide USPI
Features Gallery Product Description Request A Quote
Features
Specifications
Grade: Pharmaceutcial Grade
Function: Pharmaceuticals
CAS: 782487-28-9
Purity: 99%
Shelf Life: 2 Years
Test Method: HPLC UV
Storage: Cool Dry Place
Shipping Method: Air(UPS, FedEx, TNT, EMS) Or Sea
MF: C187H291N45O59
Service: Professional & Rich Experience
High Light:

Semaglutide Ozempic CAS 910463-68-2

,

Semaglutide Ozempic 21mg/Vial

,

Semaglutide Ozempic 5mg/Vial

Basic Infomation
Payment & Shipping Terms
Packaging Details: 10 vials/ box
Delivery Time: 2-3 days
Payment Terms: D/A, D/P, L/C, T/T, Western Union, MoneyGram
Supply Ability: 100000 vials per month
Product Description

 

Semaglutide Ozempic CAS No 910463-68-2 Peptide 2mg/Vial 5mg/Vial Semaglutide USPI

 

Product Description

 

Semaglutide has a chemical structure that is very similar to the hormone glucagon-like peptide 1 (GLP-1), which regulates both insu,lin secretion and appetite. In December, the US Food and Drug Administration approved the semaglutide injection Ozempic as a once-weekly adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Semaglutide may help people with obesity lose weight. A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight, a new study suggests.

 

Product Name Semaglutide
CAS NO. 910463-68-2
Appearance White Powder
Purity 99% or customized
Application Drug peptides
Usage Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Help people with obesity lose weight.

 

 

Applications
 
Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus. Semaglutide is a glucagon-like peptide 1 (GLP-1) analog used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity.1,15 Other members of this drug class include Exenatide and Liraglutide. Semaglutide was developed by Novo Nordisk and approved by the FDA for subcutaneous injection in December 2017.
 

Semaglutide Ozempic CAS No 910463-68-2 Peptide 2mg/Vial 5mg/Vial Semaglutide USPI 0

Recommended Products
Get in touch with us
Contact Person : Nancylee
Tel : +86 15508667508
Characters Remaining(20/3000)